scispace - formally typeset
M

Mithra T. Rothfeder

Researcher at NovoBiotic Pharmaceuticals

Publications -  4
Citations -  52

Mithra T. Rothfeder is an academic researcher from NovoBiotic Pharmaceuticals. The author has contributed to research in topics: Methicillin-resistant Staphylococcus aureus & Nocardia. The author has an hindex of 2, co-authored 4 publications receiving 47 citations.

Papers
More filters
Journal ArticleDOI

Neocitreamicins I and II, Novel Antibiotics with Activity against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci

TL;DR: Two novel antibiotics, neocitreamicins I and II, were isolated from a fermentation broth of a Nocardia strain and showed in vitro activity against Gram-positive bacteria including strains of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
Journal ArticleDOI

Isofuranonaphthoquinone produced by an Actinoplanes isolate.

TL;DR: A new isofuranonaphthoquinone was isolated from cultures of an Actinoplanes isolate obtained using an in situ diffusion technology that facilitates the isolation of soil microorganisms and was demonstrated to have the ability to complex Fe(III).
Patent

Novel macrolactam compounds

TL;DR: In this article, the authors discuss the development of macrolactams and their analogs, processes for the preparation of these novel macroglactams, and pharmaceutical compositions comprising of the novel macro-actams; and methods of using the macroactams to treat or inhibit various disorders.
Journal ArticleDOI

Neocitreamicins I and II, Novel Antibiotics with Activity Against Methicillin‐Resistant Staphylococcus aureus and Vancomycin‐Resistant Enterococci.

TL;DR: In this paper, two novel antibiotics, neocitreamicins I and II, were isolated from a fermentation broth of a Nocardia strain using an in situ diffusion chamber that facilitates the cultivation of soil microorganisms.